You just read:

BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn® in ALS

News provided by

BrainStorm Cell Therapeutics Inc.

Jul 25, 2017, 07:00 ET